Menopause News

Research continued to explore new treatments for vasomotor symptoms, the connections between menopause and cardiovascular and bone health and more in 2021. Here are the top stories from Healio’s coverage throughout the year.

Researchers found a significant association between the menopausal status of women aged 45 to 54 years and overactive bladder, according to a study published in Menopause.

Race and ethnicity as well as menopausal status are significant factors that affect the number and severity of the gastrointestinal symptoms that midlife women experience, according to a study published in Menopause.

Despite potential side effects, bisphosphonate therapy may benefit postmenopausal women with osteoporosis by preventing fractures, according to a study published in JAMA Internal Medicine.

Reproductive history events indicating more estrogen exposure correlated with larger gray matter volume in midlife women, according to a study published in Neurology.

Menopausal women experiencing vasomotor symptoms are less likely to have sarcopenia compared with those who do not have vasomotor symptoms, according to a study published in Menopause.

Menopausal hormone therapy does not affect risks for cardiovascular disease or type 2 diabetes, according to findings from a study of middle-aged postmenopausal women in South Korea published in Menopause.

Older women who primarily ate alone were more likely to have angina and worse nutrition than those who ate with others, according to a South Korean study published in the journal Menopause.

HIV and menopausal stage are both independent predictors of lower bone mineral density in women, particularly in the lumbar spine and hip, according to a study published in Clinical Infectious Diseases.

Changes in menstrual cycle lengths as women approach menopause may indicate CVD risks, according to a study published in Menopause.